Axcella Health's Series D Round

Axcella Health raised a round of funding on February 23, 2016. Investors include Nestle Health Science.

Axcella Health, formerly Pronutria Biosciences, is pioneering revolutionary new medicines with a focus on amino acid homeostasis. The company has discovered more than 2,000 diseases with amino acid im…

Articles about Axcella Health's Series D Round: